Exploring the nexus between myocardial microcirculation perfusion and contractile mechanics in nonobstructive

Jing Nan1,2, Lina Guan1,2, Chao Yuan3

  • 1Department of Cardiac Ultrasound, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

Insights

Myocardial microcirculation perfusion and global longitudinal strain (GLS) are impaired in nonobstructive hypertrophic cardiomyopathy (HCM) patients. Damage is more pronounced in hypertrophic segments, linked to altered mechanical properties.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Hypertrophic cardiomyopathy (HCM) can present without obstructive features.
  • Understanding microcirculation and mechanical properties in nonobstructive HCM is crucial for patient management.
  • Previous studies have not fully elucidated the interplay between perfusion and mechanics in this specific HCM subtype.

Purpose of the Study:

  • To quantitatively analyze myocardial microcirculation perfusion in nonobstructive HCM patients.
  • To evaluate the mechanical properties of the myocardium in nonobstructive HCM.
  • To investigate the correlation between perfusion and mechanical characteristics in hypertrophic segments.

Main Methods:

  • Study included 28 nonobstructive HCM patients and 28 healthy controls.
  • Utilized two-dimensional echocardiography, contrast-enhanced myocardial ultrasound (MCE), and 2D speckle tracking imaging.
  • Classified nonobstructive HCM patients into hypertrophic segmental (HS) and non-hypertrophic segmental myocardium groups.

Main Results:

  • No significant demographic differences between HCM and control groups.
  • Significant disparities in myocardial perfusion and mechanical properties observed in nonobstructive HCM.
  • Global longitudinal strain (GLS) was significantly decreased in nonobstructive HCM patients; HS showed a positive correlation between perfusion and mechanical parameters.

Conclusions:

  • Myocardial microcirculation perfusion and GLS are impaired in nonobstructive HCM.
  • Hypertrophic segments (HS) exhibit more pronounced damage, closely associated with altered myocardial mechanical characteristics.
  • These findings highlight the importance of assessing both perfusion and mechanics in nonobstructive HCM.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
816
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
65
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
72
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K